Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures

NCT02960347 is registered in ClinicalTrials.gov with Herzog Hospital as lead sponsor.

NCT NCT02960347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02960347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures
Lead sponsor
Herzog Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2016
Completion date
June 30, 2016
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ohtahara syndrome